CNS vs PLMR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CNS exhibits a stable financial foundation with a Piotroski F-Score of 5/9 and very low debt (D/E 0.22), but it is fundamentally overvalued. The current price of $67.71 trades at a significant premium to both the Graham Number ($27.35) and the growth-based Intrinsic Value ($50.59). This valuation gap is compounded by a bearish technical trend (0/100), insider selling, and a dangerously high dividend payout ratio of 83.77%. Recent earnings performance is lackluster, with only one beat in the last four quarters.
PLMR exhibits a stable financial health profile with a Piotroski F-Score of 4/9 and an exceptionally clean balance sheet (Debt/Equity 0.01). While the stock trades at a significant premium to its Graham Number ($75.73), it remains well below its growth-based intrinsic value of $211.51. The company is experiencing explosive growth, with revenue and earnings both increasing by approximately 60% YoY, supported by a strong ROE of 23.58%. Despite bearish insider activity and technicals, the fundamental growth trajectory and attractive forward P/E of 11.86 suggest significant upside.
Compare Another Pair
Related Comparisons
CNS vs PLMR: Head-to-Head Comparison
This page compares Cohen & Steers, Inc. (CNS) and Palomar Holdings, Inc. (PLMR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.